Browsing by Author "Chatterjee, Soumya"

Now showing 1 - 3 of 3
  • Thumbnail Image
    ItemOpen Access
    Advances in Color Science: From Retina to Behavior (vol 30, pg 14955, 2010)
    (JOURNAL OF NEUROSCIENCE, 2010-12-08) Conway, Bevil R; Chatterjee, Soumya; Field, Greg D; Horwitz, Gregory D; Johnson, Elizabeth N; Koida, Kowa; Mancuso, Katherine
  • Thumbnail Image
    ItemOpen Access
    Advances in color science: from retina to behavior.
    (The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010-11) Conway, Bevil R; Chatterjee, Soumya; Field, Greg D; Horwitz, Gregory D; Johnson, Elizabeth N; Koida, Kowa; Mancuso, Katherine
    Color has become a premier model system for understanding how information is processed by neural circuits, and for investigating the relationships among genes, neural circuits, and perception. Both the physical stimulus for color and the perceptual output experienced as color are quite well characterized, but the neural mechanisms that underlie the transformation from stimulus to perception are incompletely understood. The past several years have seen important scientific and technical advances that are changing our understanding of these mechanisms. Here, and in the accompanying minisymposium, we review the latest findings and hypotheses regarding color computations in the retina, primary visual cortex, and higher-order visual areas, focusing on non-human primates, a model of human color vision.
  • Thumbnail Image
    ItemOpen Access
    Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.
    (Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018-06-25) Sullivan, Keith M; Majhail, Navneet S; Bredeson, Christopher; Carpenter, Paul A; Chatterjee, Soumya; Crofford, Leslie J; Georges, George E; Nash, Richard A; Pasquini, Marcelo C; Sarantopoulos, Stefanie; Storek, Jan; Savani, Bipin; St Clair, E William
    Systemic sclerosis is a progressive inflammatory disease that is frequently fatal and has limited treatment options. High-dose chemotherapy with autologous hematopoietic cell transplantation (AHCT) has been evaluated as treatment for this disease in observational studies, multicenter randomized controlled clinical trials, and meta-analyses. On behalf of the American Society for Blood and Marrow Transplantation (ASBMT), a panel of experts in transplantation and rheumatology was convened to review available evidence and make a recommendation on AHCT as an indication for systemic sclerosis. Three randomized trials have compared the efficacy of AHCT with cyclophosphamide only, and all demonstrated benefit for the AHCT arm for their primary endpoint (improvement in the American Scleroderma Stem Cell versus Immune Suppression Trial, event-free survival in Autologous Stem Cell Transplantation International Scleroderma trial, and change in global rank composite score in Scleroderma: Cyclophosphamide or Transplantation trial). AHCT recipients also had better overall survival and a lower rate of disease progression. These findings have been confirmed in subsequent meta-analyses. Based on this high-quality evidence, the ASBMT recommends systemic sclerosis should be considered as a "standard of care" indication for AHCT. Close collaboration between rheumatologists and transplant clinicians is critical for optimizing patient selection and patient outcomes. Transplant centers in the United States are strongly encouraged to report patient and outcomes data to the Center for International Blood and Marrow Transplant Research on their patients receiving AHCT for this indication.